The Israeli public health response to wild poliovirus importation

The Lancet Infectious Diseases

Volumn 15, Issue 10, 2015, Pages 1236-1242

  Kaliner, Ehud ^a   Kopel, Eran ^a   Anis, Emilia ^a,b   Mendelson, Ella ^a,d   Moran Gilad, Jacob ^a,c   Shulman, Lester M ^a,d   Singer, Shepherd R ^a   Manor, Yossi ^a   Somekh, Eli ^d,e   Rishpon, Shmuel ^a,f   Leventhal, Alex ^a   Rubin, Lisa ^a,f   Tasher, Diana ^d,e   Honovich, Mira ^a   Moerman, Larisa ^a   Shohat, Tamy ^a,d   Bassal, Ravit ^a,d   Sofer, Danit ^a   Gdalevich, Michael ^a,c   Lev, Boaz ^a   Gamzu, Ronni ^a,d   Grotto, Itamar ^a,c   more..

^a MINISTRY OF HEALTH   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

^e WOLFSON MEDICAL CENTER   (Israel)

^f UNIVERSITY OF HAIFA   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL POLIOMYELITIS VACCINE;

CLINICAL DECISION MAKING; DISEASE ERADICATION; EVIDENCE BASED PRACTICE; HEALTH CARE POLICY; HUMAN; HUMAN POLIOVIRUS 1; ISRAELI; NOTE; POLIOMYELITIS; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; VACCINATION; WORLD HEALTH ORGANIZATION; CHILD; DIAGNOSIS; EPIDEMIOLOGICAL MONITORING; EPIDEMIOLOGY; FEMALE; HETEROZYGOTE; INFANT; INFECTION CONTROL; ISOLATION AND PURIFICATION; ISRAEL; MALE; MICROBIOLOGY; NEWBORN; POLIOMYELITIS VIRUS; PRESCHOOL CHILD; PROCEDURES; PUBLIC HEALTH SERVICE; TRAVEL;

CARRIER STATE; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASE CONTROL; ENVIRONMENTAL MICROBIOLOGY; EPIDEMIOLOGICAL MONITORING; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; ISRAEL; MALE; POLIOMYELITIS; POLIOVIRUS; PUBLIC HEALTH ADMINISTRATION; TRAVEL;

EID: 84942196262     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(15)00064-X     Document Type: Note

References (37)

1. Global Polio Eradication Initiative: 10th meeting of the Independent Monitoring Board. Wkly Epidemiol Rec 2014, 89:361-367. Global Polio Eradication Initiative.
2. Nathanson N, Kew OM From emergence to eradication: the epidemiology of poliomyelitis deconstructed. Am J Epidemiol 2010, 172:1213-1229.
3. Kimman TG, Boot H The polio eradication effort has been a great success-let's finish it and replace it with something even better. Lancet Infect Dis 2006, 6:675-678.
4. Bhutta ZA Conflict and polio: winning the polio wars. JAMA 2013, 310:905-906.
5. Tangermann RH, Hull HF, Jafari H, Nkowane B, Everts H, Aylward RB Eradication of poliomyelitis in countries affected by conflict. Bull World Health Organ 2000, 78:330-338.
6. Wassilak SG, Oberste MS, Tangermann RH, Diop OM, Jafari HS, Armstrong GL Progress toward global interruption of wild poliovirus transmission, 2010-2013, and tackling the challenges to complete eradication. J Infect Dis 2014, 210(suppl 1):S5-S15.
7. Acute flaccid paralysis surveillance: a global platform for detecting and responding to priority infectious diseases. Wkly Epidemiol Rec 2004, 79:425-432.
8. Swartz TA The epidemiology of polio in Israel. An historical perspective. Publication 317 2008, Israel Center for Disease Control (ICDC), Ministry of Health, Tel Aviv, (accessed May 26, 2015). http://www.health.gov.il/PublicationsFiles/ICDC_317.pdf.
9. WHO vaccine-preventable diseases: monitoring system. 2014 global summary. Geneva: World Health Organization WHO, (accessed Aug 24, 2014). http://apps.who.int/immunization_monitoring/globalsummary/coverages?c=ISR.
10. Slater PE, Orenstein WA, Morag A, et al. Poliomyelitis outbreak in Israel in 1988: a report with two commentaries. Lancet 1990, 335:1192-1195.
11. Shulman LM, Gavrilin E, Jorba J, et al. Molecular epidemiology of silent introduction and sustained transmission of wild poliovirus type 1, Israel, 2013. Euro Surveill 2014, 19:20709.
12. Manor Y, Shulman LM, Kaliner E, et al. Intensified environmental surveillance supporting the response to wild poliovirus type 1 silent circulation in Israel, 2013. Euro Surveill 2014, 19:20708.
13. Anis E, Kopel E, Singer SR, et al. Insidious reintroduction of wild poliovirus into Israel, 2013. Euro Surveill 2013, 18:20586.
14. Kaliner E, Moran-Gilad J, Grotto I, et al. Silent reintroduction of wild-type poliovirus to Israel, 2013-risk communication challenges in an argumentative atmosphere. Euro Surveill 2014, 19:20703.
15. Shulman LM, Mendelson E, Anis E, et al. Laboratory challenges in response to silent introduction and sustained transmission of wild poliovirus type 1 in Israel during 2013. J Infect Dis 2014, 210(suppl 1):S304-S314.
16. Polio laboratory manual 2004, WHO, World Health Organization, Geneva, (accessed May 26, 2015). http://whqlibdoc.who.int/hq/2004/WHO_IVB_04.10.pdf, 4th edn.
17. Manor Y, Blomqvist S, Sofer D, et al. Advanced environmental surveillance and molecular analyses indicate separate importations rather than endemic circulation of wild type 1 poliovirus in Gaza district in 2002. Appl Environ Microbiol 2007, 73:5954-5958.
18. Hindiyeh MY, Moran-Gilad J, Manor Y, et al. Development and validation of a real time quantitative reverse transcription-polymerase chain reaction (qRT-PCR) assay for investigation of wild poliovirus type 1-South Asian (SOAS) strain reintroduced into Israel, 2013 to 2014. Euro Surveill 2014, 19:20710.
19. Shulman LM, Martin J, Sofer D, et al. Genetic analysis and characterization of wild poliovirus type 1 during sustained transmission in a population with >95% vaccine coverage, Israel 2013. Clin Infect Dis 2015, 60:1057-1064.
20. Hovi T, Shulman LM, van der Avoort H, Deshpande J, Roivainen M, de Gourville EM Role of environmental poliovirus surveillance in global polio eradication and beyond. Epidemiol Infect 2012, 140:1-13.
21. Supplemental polio vaccination campaign State of Israel Ministry of Health, (accessed Aug 24, 2014). http://www.health.gov.il/English/Topics/Vaccination/two_drops/Pages/default.aspx.
22. Report of the 26th Meeting of the European Regional Certification Commission for Poliomyelitis Eradication. Copenhagen, Denmark, June 18-20, 2012 2012, WHO, World Health Organization Regional Office for Europe, Copenhagen, (accessed May 26, 2015). http://www.euro.who.int/__data/assets/pdf_file/0005/184739/e96806.pdf.
23. Scientific evidence in support of: Note for the record: 5th meeting of the SAGE Working Group, World Health Organization, Geneva, September 3-4, 2012 2012, WHO, World Health Organization, Geneva, (accessed May 26, 2015). http://www.who.int/immunization/sage/meetings/2012/november/3__SAGE_WG_Scientific_Evidence22Oct2012.pdf.
24. Jenkins HE, Aylward RB, Gasasira A, et al. Implications of a circulating vaccine-derived poliovirus in Nigeria. N Engl J Med 2010, 362:2360-2369.
25. Burns CC, Shaw J, Jorba J, et al. Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria. J Virol 2013, 87:4907-4922.
26. Adu F, Iber J, Bukbuk D, et al. Isolation of recombinant type 2 vaccine-derived poliovirus (VDPV) from a Nigerian child. Virus Res 2007, 127:17-25.
27. Alexander JP, Gary HE, Pallansch MA Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature. J Infect Dis 1997, 175(suppl 1):S176-S182.
28. Hird TR, Grassly NC Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge. PLoS Pathog 2012, 8:e1002599.
29. Swartz TA, Green MS, Handscher R, et al. Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel. Vaccine 2008, 26:1083-1090.
30. Shulman LM, Handsher R, Yang CF, et al. Resolution of the pathways of poliovirus type 1 transmission during an outbreak. J Clin Microbiol 2000, 38:945-952.
31. Oostvogel PM, van Wijngaarden JK, van der Avoort HG, et al. Poliomyelitis outbreak in an unvaccinated community in the Netherlands, 1992-93. Lancet 1994, 344:665-670.
32. Hovi T, Cantell K, Huovilainen A, et al. Outbreak of paralytic poliomyelitis in Finland: widespread circulation of antigenically altered poliovirus type 3 in a vaccinated population. Lancet 1986, 1:1427-1432.
33. GAPIII 2014 (April 29, 2015 revision). WHO global action plan to minimize poliovirus facility-associated risk after type-specific eradication of wild polioviruses and sequential cessation of OPV use. Geneva: World Health Organization (accessed May 26, 2015). http://www.polioeradication.org/Portals/0/Document/Resources/PostEradication/GAPIII_2014.pdf.
34. Hovi T, Stenvik M, Partanen H, Kangas A Poliovirus surveillance by examining sewage specimens. Quantitative recovery of virus after introduction into sewerage at remote upstream location. Epidemiol Infect 2001, 127:101-106.
35. Lodder WJ, Buisman AM, Rutjes SA, Heijne JC, Teunis PF, de Roda Husman AM Feasibility of quantitative environmental surveillance in poliovirus eradication strategies. Appl Environ Microbiol 2012, 78:3800-3805.
36. Kopel E, Kaliner E, Grotto I Lessons from a public health emergency-importation of wild poliovirus to Israel. N Engl J Med 2014, 371:981-983.
37. Siegel-Itzkovich J The Jerusalem Post (Jerusalem) (accessed May 26, 2015). http://www.jpost.com/Breaking-News/WHO-declares-Israel-polio-free-400572.